rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

The company

Viemed Healthcare, Inc. - Common Shares

VMD · Nasdaq

Health CareProviders & FacilitiesSetting up

VMD stood above a rising 150-day average in 34 of the last 52 weekly readings, and has been out of that trend for the last 10 weeks. It is 4.2% below that average now. Providers & Facilities: 45% of its 53 stocks in an uptrend (−6 points in four weeks); Health Care: 25% (−11 points in four weeks).

Statistics

Rotation
Setting up
Weeks in an uptrend
out for 10
Industry in uptrend
45% -6 in 4 wk
Insider buys, 12 months
$0
Insider sales, 12 months
$3.2M
Officials’ trades on record
0
Institutions holding
156 (+20)

In the rotation

Each square a week: lit when it closed above a rising 150-day average. 34 of 52 weeks.

17 Apr – 16 Oct
26%43%59%Apr 26Jun 26Jul 26Sep 26Oct 26

Providers & Facilities: About half its stocks are in an uptrend and the share has been slipping. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.

Money in and out

1 Nov 2024 – 1 Oct 2026
−$2.4M$0Nov 24May 25Nov 25Apr 26Oct 26

Open-market buys above the line and sales below, in dollars.

Congress and officials

No member of Congress or official has disclosed a trade in it.

Insiders

Buy orders, 12 months0
Sale orders, 12 months5
Buyers · sellers0 · 3
WhoDidSharesTraded
William FrazierChief Medical Officersold10,000at $11.7225 Jun 2026filed 26 Jun 2026
Timothy SmokoffDirectorsold1,636at $11.4824 Jun 2026filed 26 Jun 2026
Timothy SmokoffDirectorsold3,364at $11.5024 Jun 2026filed 26 Jun 2026
Timothy SmokoffDirectorsold5,000at $11.5624 Jun 2026filed 26 Jun 2026
Timothy SmokoffDirectorsold5,000at $11.5324 Jun 2026filed 26 Jun 2026
Timothy SmokoffDirectorsold5,000at $11.4124 Jun 2026filed 26 Jun 2026
Michael MoorePresidentsold65,000at $8.7720 Mar 2026filed 20 Mar 2026
Michael MoorePresidentsold40,232at $9.2119 Mar 2026filed 20 Mar 2026
Michael MoorePresidentsold31,570at $9.4218 Mar 2026filed 20 Mar 2026

Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.

Institutions

Holders156+20 on the quarter
New · exited30 · 10
Reported value$284.3M

Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.

ManagerSharesChange
BlackRock, Inc.added · filed 7 Aug 20264,788,307$54.6M+165,745+3.6%
Forager Capital Management, LLCreduced · filed 14 Aug 20262,141,184$24.4M-684,687−24.2%
VANGUARD CAPITAL MANAGEMENT LLCadded · filed 13 Aug 20261,321,676$15.1M+18,292+1.4%
GOLDMAN SACHS GROUP INCreduced · filed 14 Aug 20261,222,534$13.9M-199,100−14.0%
AMERIPRISE FINANCIAL INCadded · filed 14 Aug 20261,006,195$11.5M+107,876+12.0%
GEODE CAPITAL MANAGEMENT, LLCadded · filed 12 Aug 2026973,744$11.1M+194,222+24.9%
ARROWSTREET CAPITAL, LIMITED PARTNERSHIPadded · filed 13 Aug 2026786,269$9.0M+75,083+10.6%
STATE STREET CORPadded · filed 7 Aug 2026762,097$8.7M+19,138+2.6%
Nantahala Capital Management, LLCreduced · filed 14 Aug 2026632,445$7.2M-251,338−28.4%
PANAGORA ASSET MANAGEMENT INCadded · filed 6 Aug 2026538,625$6.1M+66,528+14.1%
31 Mar 2023 – 30 Jun 2026
80117153Mar 23Dec 23Dec 24Sep 25Jun 26

News

No headline names it lately.

Everyone who traded it

Nitin Kaushal Company insiderDirector · last 19 Aug 20260 · 10
Randy E. Dobbs Company insiderDirector · last 19 Aug 20260 · 1
Sabrina Heltz Company insiderDirector · last 19 Aug 20261 · 0
Timothy Smokoff Company insiderDirector · last 19 Aug 20260 · 6
William Frazier Company insiderChief Medical Officer · last 25 Jun 20260 · 1
Michael Moore Company insiderPresident · last 20 Mar 20260 · 6
Casey Hoyt Company insiderChief Executive Officer · last 29 Jan 20260 · 0
Jeremy Trahan Company insiderGeneral Counsel · last 29 Jan 20260 · 0
Jerome Cambre Company insiderVice President of Sales · last 29 Jan 20260 · 1
Trae Fitzgerald Company insiderChief Financial Officer · last 29 Jan 20260 · 0
William Todd Zehnder Company insiderChief Operating Officer · last 29 Jan 20260 · 0
Bruce D. Greenstein Company insiderDirector · last 25 Aug 20240 · 0

Same industry

PACS PACS GroupLeading+18%

Distance from each stock’s own 150-day average.

Government contracts

No federal award is tied to it.

From its SEC filings

Profit per saleFY 2025 · to 31 Dec 202557.5%
Operating profit marginFY 2025 · to 31 Dec 20258.5%
Free cash flow marginFY 2025 · to 31 Dec 20254.4%
Return on capital employedFY 2025 · to 31 Dec 202514.5%
Cash conversionFY 2025 · to 31 Dec 2025348%
Debt to equityFY 2025 · to 31 Dec 20250.09×
Research spendFY 2025 · to 31 Dec 20251.1%
Share count trendFY 2025 · to 20 Feb 20261.5%
Cash and equivalentsFY 2025 · to 31 Dec 2025$13.5M
Free cash flowFY 2025 · to 31 Dec 2025$11.9M

Analyst forecasts

No analyst forecasts yet.